PHIO:NASDAQ
Phio Pharmaceuticals Corp
$1.03
arrow_upward
+1.98%(+0.020) 1D
Sep 11, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PHIO...
Open
$1.03
High
$1.05
Low
$1.02
Mkt. cap
11.97M
Avg. vol.
171.81K
Volume
94.42K
52-wk high
$4.19
52-wk low
$0.81
EPS
-$1.39
Beta
0.80
Shares outstanding
11.62M
No. of employees
6
Open
$1.03
High
$1.05
Low
$1.02
Mkt. cap
11.97M
Avg. vol.
171.81K
Volume
94.42K
52-wk high
$4.19
52-wk low
$0.81
EPS
-$1.39
Beta
0.80
Shares outstanding
11.62M
No. of employees
6
News stories
From web sources and news partners
Profile
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
About Phio Pharmaceuticals Corp